243 related articles for article (PubMed ID: 20307713)
1. T-cell-based therapies for malignancy and infection in childhood.
Ahmed N; Heslop HE; Mackall CL
Pediatr Clin North Am; 2010 Feb; 57(1):83-96. PubMed ID: 20307713
[TBL] [Abstract][Full Text] [Related]
2. Adoptive T-cell transfer in cancer immunotherapy.
Tey SK; Bollard CM; Heslop HE
Immunol Cell Biol; 2006 Jun; 84(3):281-9. PubMed ID: 16681825
[TBL] [Abstract][Full Text] [Related]
3. T cell-based therapies for EBV-associated malignancies.
Taylor GS
Expert Opin Biol Ther; 2004 Jan; 4(1):11-21. PubMed ID: 14680465
[TBL] [Abstract][Full Text] [Related]
4. Adoptive transfer of epstein-barr virus (EBV) nuclear antigen 1-specific t cells as treatment for EBV reactivation and lymphoproliferative disorders after allogeneic stem-cell transplantation.
Icheva V; Kayser S; Wolff D; Tuve S; Kyzirakos C; Bethge W; Greil J; Albert MH; Schwinger W; Nathrath M; Schumm M; Stevanovic S; Handgretinger R; Lang P; Feuchtinger T
J Clin Oncol; 2013 Jan; 31(1):39-48. PubMed ID: 23169501
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic chimeric antigen receptor-modified cells for adoptive cell therapy of cancer.
Marcus A; Eshhar Z
Expert Opin Biol Ther; 2014 Jul; 14(7):947-54. PubMed ID: 24661086
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of hematologic malignancy.
Heslop HE; Stevenson FK; Molldrem JJ
Hematology Am Soc Hematol Educ Program; 2003; ():331-49. PubMed ID: 14633789
[TBL] [Abstract][Full Text] [Related]
7. Adoptive T Cell Therapy for Epstein-Barr Virus Complications in Patients With Primary Immunodeficiency Disorders.
McLaughlin LP; Bollard CM; Keller MD
Front Immunol; 2018; 9():556. PubMed ID: 29616044
[TBL] [Abstract][Full Text] [Related]
8. Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation.
Kaeuferle T; Krauss R; Blaeschke F; Willier S; Feuchtinger T
J Hematol Oncol; 2019 Feb; 12(1):13. PubMed ID: 30728058
[TBL] [Abstract][Full Text] [Related]
9. Adoptive transfer of antigen-specific T-cells of donor type for immunotherapy of viral infections following allogeneic hematopoietic cell transplants.
O'Reilly RJ; Doubrovina E; Trivedi D; Hasan A; Kollen W; Koehne G
Immunol Res; 2007; 38(1-3):237-50. PubMed ID: 17917029
[TBL] [Abstract][Full Text] [Related]
10. Adoptive cellular immunotherapy for childhood malignancies.
Cooper LJ
Bone Marrow Transplant; 2008 Jan; 41(2):183-92. PubMed ID: 18026145
[TBL] [Abstract][Full Text] [Related]
11. Improving T cell therapy for cancer.
Leen AM; Rooney CM; Foster AE
Annu Rev Immunol; 2007; 25():243-65. PubMed ID: 17129181
[TBL] [Abstract][Full Text] [Related]
12. Adoptive transfer of virus-specific and tumor-specific T cell immunity.
Berger C; Turtle CJ; Jensen MC; Riddell SR
Curr Opin Immunol; 2009 Apr; 21(2):224-32. PubMed ID: 19304470
[TBL] [Abstract][Full Text] [Related]
13. T cells for viral infections after allogeneic hematopoietic stem cell transplant.
Bollard CM; Heslop HE
Blood; 2016 Jun; 127(26):3331-40. PubMed ID: 27207801
[TBL] [Abstract][Full Text] [Related]
14. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy.
Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M
Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860
[TBL] [Abstract][Full Text] [Related]
15. Generation of tumor-specific T-cell therapies.
Morris E; Hart D; Gao L; Tsallios A; Xue SA; Stauss H
Blood Rev; 2006 Mar; 20(2):61-9. PubMed ID: 15978709
[TBL] [Abstract][Full Text] [Related]
16. Obstacles to T cell migration in the tumor microenvironment.
Nicolas-Boluda A; Donnadieu E
Comp Immunol Microbiol Infect Dis; 2019 Apr; 63():22-30. PubMed ID: 30961814
[TBL] [Abstract][Full Text] [Related]
17. Non-uniform
Burns DM; Ryan GB; Harvey CM; Nagy E; Hughes S; Murray PG; Russell NH; Fox CP; Long HM
Front Immunol; 2019; 10():2489. PubMed ID: 31736946
[TBL] [Abstract][Full Text] [Related]
18. Principles of adoptive T cell cancer therapy.
June CH
J Clin Invest; 2007 May; 117(5):1204-12. PubMed ID: 17476350
[TBL] [Abstract][Full Text] [Related]
19. Adoptive T-cell therapy for EBV-associated post-transplant lymphoproliferative disease.
Bollard CM; Savoldo B; Rooney CM; Heslop HE
Acta Haematol; 2003; 110(2-3):139-48. PubMed ID: 14583674
[TBL] [Abstract][Full Text] [Related]
20. Antigen-specific T cell therapies for cancer.
Manzo T; Heslop HE; Rooney CM
Hum Mol Genet; 2015 Oct; 24(R1):R67-73. PubMed ID: 26160910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
